448 related articles for article (PubMed ID: 22497677)
41. Exercise endurance in chronic obstructive pulmonary disease patients at an altitude of 2640 meters breathing air and oxygen (FIO2 28% and 35%): a randomized crossover trial.
Maldonado D; González-García M; Barrero M; Jaramillo C; Casas A
COPD; 2014 Aug; 11(4):401-6. PubMed ID: 24111929
[TBL] [Abstract][Full Text] [Related]
42. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
Ozgür ES; Nayci SA; Özge C; Taşdelen B
Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
[TBL] [Abstract][Full Text] [Related]
43. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease.
Eves ND; Petersen SR; Haykowsky MJ; Wong EY; Jones RL
Am J Respir Crit Care Med; 2006 Oct; 174(7):763-71. PubMed ID: 16840742
[TBL] [Abstract][Full Text] [Related]
44. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.
Vassaux C; Torre-Bouscoulet L; Zeineldine S; Cortopassi F; Paz-Díaz H; Celli BR; Pinto-Plata VM
Eur Respir J; 2008 Nov; 32(5):1275-82. PubMed ID: 18550609
[TBL] [Abstract][Full Text] [Related]
45. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
[TBL] [Abstract][Full Text] [Related]
46. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III.
Albuquerque AL; Nery LE; Villaça DS; Machado TY; Oliveira CC; Paes AT; Neder JA
Eur Respir J; 2006 Nov; 28(5):939-44. PubMed ID: 16870665
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary function at peak exercise in patients with chronic heart failure.
Papazachou O; Anastasiou-Nana M; Sakellariou D; Tassiou A; Dimopoulos S; Venetsanakos J; Maroulidis G; Drakos S; Roussos C; Nanas S
Int J Cardiol; 2007 May; 118(1):28-35. PubMed ID: 16893579
[TBL] [Abstract][Full Text] [Related]
48. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
49. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
[TBL] [Abstract][Full Text] [Related]
50. Effects of high-intensity exercise training in a pulmonary rehabilitation programme for patients with chronic obstructive pulmonary disease.
Hsieh MJ; Lan CC; Chen NH; Huang CC; Wu YK; Cho HY; Tsai YH
Respirology; 2007 May; 12(3):381-8. PubMed ID: 17539842
[TBL] [Abstract][Full Text] [Related]
51. Contrasting pressure-support ventilation and helium-oxygen during exercise in severe COPD.
Hussain O; Collins EG; Adiguzel N; Langbein WE; Tobin MJ; Laghi F
Respir Med; 2011 Mar; 105(3):494-505. PubMed ID: 20851591
[TBL] [Abstract][Full Text] [Related]
52. Effects of formoterol on exercise tolerance in severely disabled patients with COPD.
Neder JA; Fuld JP; Overend T; Thirlwell J; Carter R; Stevenson R; Ward SA
Respir Med; 2007 Oct; 101(10):2056-64. PubMed ID: 17658249
[TBL] [Abstract][Full Text] [Related]
53. Comparing peak and submaximal cardiorespiratory responses during field walking tests with incremental cycle ergometry in COPD.
Hill K; Dolmage TE; Woon L; Coutts D; Goldstein R; Brooks D
Respirology; 2012 Feb; 17(2):278-84. PubMed ID: 22008290
[TBL] [Abstract][Full Text] [Related]
54. ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD.
Watz H; Troosters T; Beeh KM; Garcia-Aymerich J; Paggiaro P; Molins E; Notari M; Zapata A; Jarreta D; Garcia Gil E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2545-2558. PubMed ID: 28883722
[TBL] [Abstract][Full Text] [Related]
55. Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension.
Richter MJ; Voswinckel R; Tiede H; Schulz R; Tanislav C; Feustel A; Morty RE; Ghofrani HA; Seeger W; Reichenberger F
Respir Med; 2012 Feb; 106(2):308-13. PubMed ID: 22100539
[TBL] [Abstract][Full Text] [Related]
56. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
57. Relationship between ventilatory constraint and muscle fatigue during exercise in COPD.
Butcher SJ; Lagerquist O; Marciniuk DD; Petersen SR; Collins DF; Jones RL
Eur Respir J; 2009 Apr; 33(4):763-70. PubMed ID: 19047319
[TBL] [Abstract][Full Text] [Related]
58. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation.
Garcia-Rio F; Lores V; Mediano O; Rojo B; Hernanz A; López-Collazo E; Alvarez-Sala R
Am J Respir Crit Care Med; 2009 Sep; 180(6):506-12. PubMed ID: 19542481
[TBL] [Abstract][Full Text] [Related]
59. Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study.
Anderson W; Short P; Ross R; Lipworth BJ
BMJ Open Respir Res; 2023 Jul; 10(1):. PubMed ID: 37451701
[TBL] [Abstract][Full Text] [Related]
60. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.
O'Donnell DE; Revill SM; Webb KA
Am J Respir Crit Care Med; 2001 Sep; 164(5):770-7. PubMed ID: 11549531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
